Functional imaging in schizencephaly using [F-18]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) and single photon emission computed tomography with technetium-99m-hexamethyl-propyleneamine oxime (HMPAO-SPECT)
T. Morioka et al., Functional imaging in schizencephaly using [F-18]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) and single photon emission computed tomography with technetium-99m-hexamethyl-propyleneamine oxime (HMPAO-SPECT), NEUROSURG R, 22(2-3), 1999, pp. 99-101
We analyzed interictal [F-18]fluoro-2-deoxy-D-glucose positron emission tom
ography (FGD-PET) and single photon emission computed tomography with techn
etium-99m-hexamethyl-propyleneamine oxime (HMPAO-SPECT) in a 23-year-old fe
male with schizencephaly. She had epilepsy and mild left hemiparesis, but w
as otherwise developmentally normal. We found the glucose metabolism and pe
rfusion of the wall of the schizencephalic cleft to be identical to those o
f normal cerebral cortex. The wall of the transcerebral clefts, which were
observed to be lined by abnormally organized gray matter as a result of a m
igration disorder, demonstrated gray matter metabolic activity and perfusio
n. FDC-PET and HMPAO-SPECT were thus found to be a useful complement to mag
netic resonance imaging for evaluating schizencephaly.